Publication policy or publication bias?

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 6, 2005, Pages 1363-

  Byrnes, Graham ^a   Gurrin, Lyle ^a   Dowty, James ^a   Hopper, John L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ALLELE; DISEASE ASSOCIATION; DNA MICROARRAY; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; GENOTYPE; HEALTH CARE POLICY; MEDICAL LITERATURE; MEDICAL RESEARCH; NOTE; PLANT GENETICS; PRIORITY JOURNAL; PUBLICATION; PUBLISHING; SINGLE NUCLEOTIDE POLYMORPHISM;

EDITORIAL POLICIES; FALSE POSITIVE REACTIONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 20444411156     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0406     Document Type: Note

References (10)

1. Rebbeck TR, Martínez ME, Sellers TA, Shields PG, Wild CP, Potter JD. Genetic variation and cancer: improving the environment for publication of association studies. Clin Epidemiol Biomarkers Prev 2004;13:1985-6.
2. Sterne JAC, Davey-Smith G. Sifting the evidence-what's wrong with significance tests? BMJ 2001;322:226-31.
3. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995;57:289-300.
4. Storey JD, Tibshirani R. Statistical significance for genomewide studies. PNAS 2003;100:9440-5.
5. Altman DG. The scandal of poor medical research. BMJ 1994;308:283-4.
6. Nakao M, Bono H, Kawashima S, Kamiya T, Sato K, Goto S, Kanehisa M. Genome-scale gene expression and pathway reconstruction in KEGG. Genome Inform Ser Workshop Genome Inform 1999;10:94-103.
7. Chaves MM, Oliviera MM. Mechanisms underlying plant resilience to water deficits: prospects for water-saving agriculture. J Exp Biol 2004;55:2365-84.
8. Cordell HJ. Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet 2002;11:2463-8.
9. Altman DG, Schulz KF, Maher D, et al. for the CONSORT group. The revised CONSORT statement for reporting randomized controlled trials: explanation and collaboration. Ann Intern Med 2001;134:663-94.
10. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83000 women with breast cancer from 16 countries. Lancet 2004;363:1007-16.